A Phase 1 Single Dose Pharmacokinetic Bridging Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet (Carbidopa-levodopa) Tablets
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Levodopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Acorda Therapeutics
- 07 Oct 2016 Status changed from active, no longer recruiting to completed.
- 12 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2016 New trial record